<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00314405</url>
  </required_header>
  <id_info>
    <org_study_id>3157</org_study_id>
    <nct_id>NCT00314405</nct_id>
  </id_info>
  <brief_title>Identification of Sentinel Lymph Nodes With Methylene Blue and Isotope</brief_title>
  <official_title>Identification of Sentinel Lymph Node (SLN) in Breast Cancer Care: Clinical and Economical Evaluation of a Double Method Using Isotope and Methylene Blue Dye Injection.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the performance of a double labelling method using
      isotope and methylene blue dye injection to localize precisely Sentinel Lymph Node (SLN) in a
      series of 100 patients with infiltrative breast cancer justifying SLN excision. Method and
      patients: SLN excision will be performed on 100 patients treated for infiltrative breast
      cancer. After preoperative methylene blue dye injection and lymphoscintigraphy, individual
      localization of the radioactive and stained nodes will be performed. After the surgery, SLN
      will be submitted to serial analysis and immunohistochemistry. A comparison of the two
      methods and an economical evaluation of the complete procedure will be performed.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2006</start_date>
  <primary_completion_date type="Actual">April 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Determination of an optimized protocol for SLN identification, with a double method using isotope and methylene blue dye injection.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison of the results of SLN serial sectioning, with H&amp;E and IHC staining</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Economical evaluation of SLN procedure.</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Infiltrative Breast Cancer</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methylene blue (1%)</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rhenium sulfure</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgical procedure</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Anatomo-pathologic procedure</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with infiltrative breast cancer (diagnosed pre-operatively by core biopsy)

          -  approval and informed consent

        Exclusion Criteria:

          -  chemotherapy

          -  locoregional radiotherapy

          -  prevalent axillary lymph node
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Pierre Bellocq, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hôpitaux Universitaires de Strasbourg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Service de Gynécologie-Obstétrique, Hôpital Civil</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 11, 2006</study_first_submitted>
  <study_first_submitted_qc>April 11, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 13, 2006</study_first_posted>
  <last_update_submitted>August 7, 2008</last_update_submitted>
  <last_update_submitted_qc>August 7, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 8, 2008</last_update_posted>
  <keyword>sentinel lymph node</keyword>
  <keyword>SLN</keyword>
  <keyword>probe</keyword>
  <keyword>breast cancer</keyword>
  <keyword>lymphoscintigraphy</keyword>
  <keyword>methylene blue dye</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methylene Blue</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

